Filing Details
- Accession Number:
- 0001127602-21-016541
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-13 16:05:04
- Reporting Period:
- 2021-05-11
- Accepted Time:
- 2021-05-13 16:05:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1682852 | Moderna Inc. | MRNA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221127 | M. Lori Henderson | C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139 | General Counsel And Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-11 | 430 | $20.93 | 1,331 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-05-11 | 6,170 | $14.85 | 7,501 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-05-11 | 6,600 | $151.31 | 901 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-05-11 | 430 | $0.00 | 430 | $20.93 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-05-11 | 6,170 | $0.00 | 6,170 | $14.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 93,046 | 2029-03-08 | No | 4 | M | Direct | |
| 361,352 | 2028-06-26 | No | 4 | M | Direct |
Footnotes
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2020.
- 25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- 25% of this option will vest and become exercisable on April 9, 2019 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
Billionaire Hedge Funds
